| |
| |
|
| Insider
Information: |
Torley Helen |
| Relationship: |
Director |
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
683,004 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$31,666,361 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
683,004 |
|
|
| Total
Value |
$31,666,361 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
2
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-2.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -28.8%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Onyx Pharmaceuticals Inc |
ONXX |
EVP, Chief Commercial ... |
2013-10-01 |
0 |
2011-08-29 |
0 |
Premium* |
|
|
Halozyme Therapeutics Inc |
HALO |
|
2024-02-16 |
676,744 |
2014-09-16 |
0 |
Premium* |
|
|
Relypsa Inc |
RLYP |
Director |
2016-09-01 |
0 |
2015-06-04 |
0 |
Premium* |
|
|
Quest Diagnostics Inc |
DGX |
Director |
2021-05-25 |
6,260 |
2018-05-15 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
169 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 6 of 7
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| HALO |
Halozyme Therapeutics Inc |
President and CEO |
• • – |
2017-02-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
31,250 |
244,159 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
President and CEO |
• • – |
2018-02-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
31,250 |
325,136 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
President and CEO |
• • – |
2019-02-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
31,250 |
396,798 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
PRESIDENT AND CEO |
• • – |
2023-02-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
31,281 |
618,458 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
PRESIDENT AND CEO |
• • – |
2024-02-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
31,281 |
654,947 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
President and CEO |
• • – |
2021-02-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
31,282 |
501,804 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
President and CEO |
• • – |
2022-02-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
31,282 |
568,442 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
President and CEO |
• • – |
2015-12-31 |
4 |
A |
$0.00 |
$0 |
D/D |
31,500 |
99,581 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
PRESIDENT AND CEO |
• • – |
2024-02-15 |
4 |
A |
$0.00 |
$0 |
D/D |
32,781 |
676,841 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
PRESIDENT AND CEO |
• • – |
2023-02-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
32,794 |
634,783 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
President and CEO |
• • – |
2020-02-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
32,795 |
472,452 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
President and CEO |
• • – |
2021-02-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
32,795 |
519,090 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
President and CEO |
• • – |
2022-02-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
32,795 |
584,639 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
Chief Opertaing Officer |
• – – |
2011-08-29 |
4 |
A |
$0.00 |
$0 |
D/D |
34,500 |
34,500 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
PRESIDENT AND CEO |
• • – |
2024-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
37,884 |
685,814 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
President and CEO |
• • – |
2018-02-22 |
4 |
OE |
$0.00 |
$0 |
D/D |
39,354 |
348,997 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
President and CEO |
• • – |
2019-02-22 |
4 |
OE |
$0.00 |
$0 |
D/D |
39,354 |
436,091 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
President and CEO |
• • – |
2020-02-22 |
4 |
OE |
$0.00 |
$0 |
D/D |
39,354 |
510,033 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
President and CEO |
• • – |
2021-02-22 |
4 |
OE |
$0.00 |
$0 |
D/D |
39,354 |
556,671 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
President and CEO |
• • – |
2014-09-16 |
4 |
B |
$8.92 |
$446,000 |
D/D |
50,000 |
50,000 |
2.81 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
President and CEO |
• • – |
2020-11-25 |
4 |
OE |
$14.66 |
$733,000 |
D/D |
50,000 |
530,522 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
President and CEO |
• • – |
2020-11-25 |
4 |
S |
$40.17 |
$2,036,568 |
D/D |
(50,000) |
480,522 |
0 |
% |
|
| HALO |
Halozyme Therapeutics Inc |
President and CEO |
• • – |
2021-02-01 |
4 |
OE |
$14.66 |
$733,000 |
D/D |
50,000 |
520,522 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
President and CEO |
• • – |
2021-02-01 |
4 |
AS |
$47.76 |
$2,391,918 |
D/D |
(50,000) |
470,522 |
0 |
% |
|
| HALO |
Halozyme Therapeutics Inc |
President and CEO |
• • – |
2021-03-01 |
4 |
AS |
$45.58 |
$2,309,454 |
D/D |
(50,000) |
537,160 |
0 |
% |
|
169 Records found
|
|
Page 6 of 7 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
